Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
07/2003
07/02/2003EP1322302A2 Taxoid conjugates as antimitotic and antitumor agents
07/01/2003US6586464 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same
06/2003
06/26/2003US20030120069 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease
06/26/2003US20030119864 Farnesyl transferase inhibitors
06/26/2003US20030119848 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance
06/26/2003US20030119837 Pharmaceutical composition for the treatment of CNS and other disorders
06/25/2003CN1425669A Tetracyclic fluoroquinolone carboxylic acid, its preparing method and medicinal composition with it as active component
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/19/2003WO2003050122A2 Mitotic kinesin inhibitors
06/19/2003WO2003050082A2 Regioisomerically pure oxochlorins and methods of synthesis
06/19/2003WO2003050064A2 Mitotic kinesin inhibitors
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049527A2 Mitotic kinesin inhibitors
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/19/2003CA2467916A1 Mitotic kinesin inhibitors
06/19/2003CA2467726A1 Mitotic kinesin inhibitors
06/19/2003CA2467722A1 Thienopyrimidinone derivatives as mitotic kinesin inhibitors
06/18/2003EP1319011A1 Triazolo-epothilones
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319000A1 1-azabicyclo 2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/12/2003WO2003048167A1 Trioxane derivatives
06/12/2003WO2003048132A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands
06/12/2003WO2003048120A2 2-aryl pyrrologpyrimidines for a1 and a3 receptors
06/12/2003US20030109562 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1, 6,9-trioxa-3-aza-cyclopenta[a]naphthalene
06/12/2003CA2469224A1 Trioxane derivatives
06/12/2003CA2468893A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands
06/11/2003EP1317459A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/10/2003US6576768 Preparation of alkylthio- and/or arylthio-substituted diketo-diaryl-pyrrolopyrroles
06/05/2003WO2003045942A2 Chemokine receptor antagonists and methods of use thereof
06/05/2003WO2002104072A3 Emissive multichromophoric systems
06/05/2003US20030105089 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
06/04/2003EP1315729A1 Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction
06/04/2003EP1315728A1 Process for the preparation of vitronectin receptor antagonists
06/04/2003EP1315492A2 A method for treating allergies using substituted pyrazoles
06/04/2003EP1315490A2 A method for treating allergies using substituted pyrazoles
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0966414B1 Triarylmethyl free radicals as image enhancing agents
06/04/2003EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/04/2003CN1422269A 1H-imidazopyridine derivatives
06/04/2003CN1422256A Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
06/04/2003CN1421437A Bridged peryleneone/quinolindeone
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/03/2003US6573283 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
05/2003
05/30/2003WO2003044024A1 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
05/30/2003WO2003044023A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044018A1 1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid amides
05/30/2003CA2467542A1 1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid amides
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/28/2003EP1314754A1 Bridged Perinones/Quinophtalones
05/28/2003EP1313734A2 Aza heterocyclic derivatives and their therapeutic use
05/28/2003EP1073659B1 Preparation of alkylthio- and/or arylthio-substituted diketo-diaryl-pyrrolopyrroles
05/27/2003CA2412553A1 Bridged perinones/quinophthalones
05/27/2003CA2213054C Novel bis(imido) derivatives, a process for their preparation and pharmaceutical compositions containing them
05/22/2003WO2003016272A3 Improving bioavailability of carbapewem salts by nanofiltration
05/22/2003WO2002085886A3 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
05/22/2003WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
05/22/2003US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
05/22/2003US20030096836 2-Aroylimidazole compounds for treating cancer
05/22/2003US20030096812 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
05/22/2003US20030096705 Antagonists of MCP-1 function and methods of use thereof
05/22/2003US20030096254 Enhancing resonance ability of oligonuclotide probes for use in hybridization assays; gene expression
05/21/2003EP1311487A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/21/2003CN1419560A Anti-infective actatm
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566367 Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines
05/20/2003US6566360 2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors
05/20/2003US6566086 Diagnostic kit for detecting creatine levels
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092700 Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
05/15/2003US20030091861 Compounds with both charge transporting function and the luminescent function
05/14/2003EP1309593A2 Substituted pyrazoles
05/14/2003EP1309592A2 Substituted pyrazoles
05/14/2003EP0932609B1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO 2,3-e]INDOL-8-ONE
05/14/2003CN1418099A Choice compound for treatment of fibromyalgia and chronic fatigue syndrome
05/13/2003US6562806 Pyrrolobenzodiazepines
05/13/2003US6562564 Decreasing cell proliferation by decreasing levels of PP5
05/13/2003CA2211681C Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
05/08/2003WO2003037904A1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
05/08/2003WO2003037898A1 Pyrimido [4,5-b] indole derivatives
05/08/2003WO2003037896A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003WO2002048152A3 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
05/08/2003WO2002039953A9 Texaphyrin coordination compounds and uses thereof
05/08/2003US20030088112 Comprising at least two moieties, each moiety being comprised of two or more thiophenes fused directly to each other; used to fabricate thin-film transistors (TFTs) or field-effect transistors (FETs).
05/08/2003US20030087916 Pyrimidin-4-one compounds
05/08/2003US20030087892 Condensed azepines as vasopressin agonists
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2464934A1 Pyrimido [4,5-b] indole derivatives
05/08/2003CA2464194A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1307451A2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido 2,3-d]pyrimidin-7-ones
05/07/2003EP1307439A2 Synthetic salicylihalamides, apicularens and derivatives thereof
05/07/2003EP1307200A2 Substituted-triazolopyrimidines as anticancer agents
05/06/2003USRE38117 Trioxane dimer compound having antiproliferative and antitumor activities
05/06/2003US6559309 Preparation for camptothecin and camptothecin-like compounds and to novel intermediates used in this preparation. The process for the preparation of the camptothecin derivative known by 7-(4
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 111